Case File
efta-efta00879081DOJ Data Set 9OtherFrom: "Rich Kahn" cj
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00879081
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Rich Kahn" cj
To: "jeffrey epstein" <jeevacation(%.gmail.com>
Subject: FW: Requested Documents
Date: Wed, 05 Jan 2011 14:33:39 +0000
Attachments: BE_Trim_view_1_2011.xls; SMG_Proj_2011-201221010411.xls
I spoke with Adam last night and reviewed attached this morning. I continue to have concerns about ability of Seed to
meet targets and follow plan of cutting expenses. Two disturbing things from call and numbers are:
a) Adam shows schedule of new 2011 breakeven budget of 1,522,355 and then his CFO says it has not yet been
implemented
b) Adams says he is trying to raise money from investors at Series C pricing giving Seed a valuation of 20,000,000 — I
asked him how he has a conscience raising funds with that valuation and his response was I am not directly
responsible as Innovium and Walnut are raising funds
In conclusion I have no trust or confidence in Adam and continue to think the best move is not to fund Seed.
Please advise
Rich Kahn
HBRK Associates Inc.
tel
fax
cell
From: Vera Savcic [mailto
Sent: Tuesday, January 04, 2011 6:25 PM
To: Rich Kahn
Cc:
Subject: Requested Documents
Hi Rich:
Happy New Year to you and your family.
Adam requested that I send you the following documents based on your conversation today, so attached please find:
1. A pared down break even analysis with lowered salaries, etc. showing an annual run rate of $1.5mm. We have not yet
initiated these changes fyi.
2. A revised cash flow based on where we stand today. I have added a few items that remain unfunded from December
but the offset is higher cash receipts this month than originally projected.
The largest change in this document is due to an error that I made in the GE recurring monthly fee. Because we expected
an extra $12k from another visualization source in January, I mistakenly copied this formula with the extra $12k across all
cells for the 12 months ending Dec 31, 2011. In other words, the cash flow receipts were overstated by $150k due to my
error. I did find this mistake a few weeks ago, but since we have not been in contact over the past several weeks I have
not had the opportunity to advise you of this. If we implement the salary changes and reduced hiring based on the pared
down BE, we will make up this difference.
Let me know if you needed anything else.
EFTA00879081
Best Regards,
Vera
EFTA00879082
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.